Bio-Rad projects 2025 currency-neutral revenue growth of 1.5%-3.5%, excluding contributions from acquisitions. Diagnostics revenue is expected to grow between 2%-3%, while Life Science revenue is ...

Shares U.S. Small-Cap Equity Factor ETF's multifactor strategy and mid-cap exposure drive outperformance with strong returns ...

Microsoft shifts from R&D to CAPEX, focusing on AI advancements like ChatGPT. Explore MSFT' stock's strategy to lead in LLMs with limitless application potential.

Explore PJM's revised load projections and for Talen Energy. I am optimistic about the potential for future capacity prices ...

Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ETCompany ParticipantsJohn Kibarian - President and ...

Shopify posted strong Q4'24 results with GMV growth, FCF margin expansion and robust core segment performance. High valuation ...

Antero Midstream surpasses free cash flow goals, balances growth with fiscal prudence, and targets high-teens returns. Read ...

Good day, and welcome to Udemy's Fourth Quarter and Full Year 2024 Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an ...

R&S Index up by 11.39%, Franco-Nevada leads with a 15.62% gain. Read here for an update on January's precious metals market ...

The QA business is expected to grow significantly, with a target of €100 million in annual revenue within a few years. CEO Varelius mentioned that QA products are gaining traction beyond the Qt ...

GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...

Qualys offers a 9% upside with a $150 price target. Learn about QLYS stock about its strong margins, share buybacks, and ...